Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected

[cafead]

via Japanese drugmaker Eisai on Thursday said the distribution of its Alzheimer's drug Leqembi in the United States has proceeded slower than it expected.
The company expects to reach 90% of its target for integrated delivery networks (IDNs) used to administer the drug in the U.S. in the fiscal year ending this month, Chief Executive Haruo Naito said.

article source